BAYLOR COLLEGE OF MEDICINE
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Pharmacogenetics of Disulfiram for Cocaine
- Conditions
- Interventions
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 93
- Registration Number
- NCT00149630
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2012-10-24
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 301
- Registration Number
- NCT00142948
- Locations
- 🇷🇺
Saint Petersburg Pavlov State Medical University, Saint Petersburg, Russian Federation
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program
- Conditions
- Interventions
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 29255
- Registration Number
- NCT00138294
- Locations
- 🇺🇸
Scott & White Hospital and Clinic, Waco, Texas, United States
Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection
- Conditions
- Interventions
- First Posted Date
- 2005-07-15
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 36
- Registration Number
- NCT00120081
- Locations
- 🇺🇸
George Washington University Medical Center, Washington, D.C., District of Columbia, United States
Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer
- Conditions
- First Posted Date
- 2004-08-02
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 175
- Registration Number
- NCT00003097
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
- First Posted Date
- 2004-06-21
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT00085930
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)
- Conditions
- Interventions
- First Posted Date
- 2004-05-05
- Last Posted Date
- 2017-02-07
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 4
- Registration Number
- NCT00082225
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸The Methodist Hospital, Houston, Texas, United States
EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
- Conditions
- First Posted Date
- 2004-03-02
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT00078546
- Locations
- 🇺🇸
The Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
- First Posted Date
- 2004-03-02
- Last Posted Date
- 2014-10-08
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 26
- Registration Number
- NCT00078533
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
- Conditions
- Interventions
- First Posted Date
- 2004-03-02
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 9
- Registration Number
- NCT00078520
- Locations
- 🇺🇸
The Methodist Hospital, Houston, Texas, United States